We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$5.3M
1-Year Est. Return
7.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.09%
1 Year Est. Return
+7.8%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.86M
AUM Growth
-$188M
(-95%)
Cap. Flow
-$186M
Cap. Flow
% of AUM
-1,882.29%
Top 10 Holdings %
Top 10 Hldgs %
17.98%
Holding
708
New
41
Increased
5
Reduced
51
Closed
611
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACV Auctions
ACVA
|
+$194K |
| 2 |
Rapid7
RPD
|
+$183K |
| 3 |
EFC
Ellington Financial
EFC
|
+$181K |
| 4 |
Banco Santander
SAN
|
+$159K |
| 5 |
Oscar Health
OSCR
|
+$155K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXL Service
EXLS
|
+$830K |
| 2 |
Delek US
DK
|
+$724K |
| 3 |
Broadcom
AVGO
|
+$669K |
| 4 |
Itron
ITRI
|
+$666K |
| 5 |
Brinker International
EAT
|
+$649K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.83% |
| 2 | Technology | 15.87% |
| 3 | Healthcare | 10.98% |
| 4 | Industrials | 10.86% |
| 5 | Real Estate | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
NovoCure
NVCR
$2.09B
| – | – |
-34,227
| Closed | -$443K |
|
477
NVIDIA
NVDA
$5.51T
| – | – |
-3,385
| Closed | -$631K |
|
478
Quanex
NX
$904M
| – | – |
-25,253
| Closed | -$388K |
|
479
Oil-Dri
ODC
$1.33B
| – | – |
-4,484
| Closed | -$219K |
|
480
Orion
OEC
$354M
| – | – |
-79,369
| Closed | -$419K |
|
481
OGE Energy
OGE
$9.51B
| – | – |
-6,614
| Closed | -$282K |
|
482
Omega Healthcare
OHI
$14B
| – | – |
-4,667
| Closed | -$207K |
|
483
O-I Glass
OI
$1.11B
| – | – |
-31,871
| Closed | -$470K |
|
484
ONE Gas
OGS
$5B
| – | – |
-5,901
| Closed | -$456K |
|
|
OLP
485
One Liberty Properties
OLP
$528M
| – | – |
-13,742
| Closed | -$279K |
|
|
ACH
486
Accendra Health
ACH
$93.1M
| – | – |
-107,865
| Closed | -$279K |
|
487
Ondas Inc
ONDS
$4.99B
| – | – |
-18,641
| Closed | -$182K |
|
488
On Holding
ONON
$9.68B
| – | – |
-5,879
| Closed | -$273K |
|
489
Ooma
OOMA
$633M
| – | – |
-12,806
| Closed | -$150K |
|
490
O'Reilly Automotive
ORLY
$71.1B
| – | – |
-3,060
| Closed | -$279K |
|
491
Orion Group Holdings
ORN
$394M
| – | – |
-10,048
| Closed | -$99.9K |
|
492
Orrstown Financial Services
ORRF
$830M
| – | – |
-13,385
| Closed | -$474K |
|
493
Otis Worldwide
OTIS
$27.2B
| – | – |
-2,385
| Closed | -$208K |
|
494
Blue Owl Capital
OWL
$8.22B
| – | – |
-14,748
| Closed | -$220K |
|
495
Phibro Animal Health
PAHC
$1.48B
| – | – |
-7,881
| Closed | -$294K |
|
496
Paymentus
PAY
$4.48B
| – | – |
-7,414
| Closed | -$234K |
|
497
Paysign
PAYS
$743M
| – | – |
-86,588
| Closed | -$446K |
|
498
PBF Energy
PBF
$8.13B
| – | – |
-10,616
| Closed | -$288K |
|
499
Petrobras
PBR
$118B
| – | – |
-38,680
| Closed | -$458K |
|
|
500
Petrobras Class A
PBR.A
$107B
| – | – |
-38,047
| Closed | -$429K |
|
Similar funds
SA
BP
WI
LAM
PFGWM
BM
OFC
AL
PharVision Advisers's Q1 2026 Portfolio in Review
As of Q1 2026, PharVision Advisers held 708 positions worth $9.86M, down 95% from $198M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
PharVision Advisers withdrew a net $186M in Q1 2026, closing 611 positions and reducing 51 holdings. Its most notable exit was EXL Service, an estimated $830K position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
Against the trend, PharVision Advisers opened a new position in ACV Auctions worth $125K.
- PharVision Advisers's largest Q1 2026 buy was ACV Auctions: 29,579 shares worth $125K.
- PharVision Advisers added most to Embecta in Q1 2026, an estimated $48.4K increase.
- PharVision Advisers's biggest Q1 2026 reduction was Herbalife, cutting an estimated $621K.
- PharVision Advisers fully exited EXL Service in Q1 2026, selling an estimated $830K.
- PharVision Advisers's ten largest holdings make up 18% of its $9.86M portfolio in Q1 2026.
- PharVision Advisers opened 41 new positions and closed 611 in Q1 2026.
- PharVision Advisers's portfolio value fell 95% quarter-over-quarter to $9.86M.
Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.